DK158728C - Analogifremgangsmaade til fremstilling af triazolon-derivater - Google Patents

Analogifremgangsmaade til fremstilling af triazolon-derivater

Info

Publication number
DK158728C
DK158728C DK112582A DK112582A DK158728C DK 158728 C DK158728 C DK 158728C DK 112582 A DK112582 A DK 112582A DK 112582 A DK112582 A DK 112582A DK 158728 C DK158728 C DK 158728C
Authority
DK
Denmark
Prior art keywords
preparation
analogy procedure
triazolone derivatives
triazolone
derivatives
Prior art date
Application number
DK112582A
Other languages
Danish (da)
English (en)
Other versions
DK158728B (da
DK112582A (da
Inventor
Jr Davis L Temple
Jr Walter G Lobeck
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK158728(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK112582A publication Critical patent/DK112582A/da
Publication of DK158728B publication Critical patent/DK158728B/da
Application granted granted Critical
Publication of DK158728C publication Critical patent/DK158728C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK112582A 1981-03-16 1982-03-12 Analogifremgangsmaade til fremstilling af triazolon-derivater DK158728C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24446481 1981-03-16
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Publications (3)

Publication Number Publication Date
DK112582A DK112582A (da) 1982-09-17
DK158728B DK158728B (da) 1990-07-09
DK158728C true DK158728C (da) 1990-12-03

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112582A DK158728C (da) 1981-03-16 1982-03-12 Analogifremgangsmaade til fremstilling af triazolon-derivater

Country Status (26)

Country Link
US (1) US4338317A (hu)
JP (1) JPS57159774A (hu)
KR (1) KR880001374B1 (hu)
AT (1) AT384022B (hu)
BE (1) BE892503A (hu)
CA (1) CA1198436A (hu)
CH (1) CH649539A5 (hu)
CY (1) CY1373A (hu)
DE (1) DE3209557A1 (hu)
DK (1) DK158728C (hu)
ES (1) ES510449A0 (hu)
FI (1) FI73670C (hu)
FR (1) FR2501690B1 (hu)
GB (1) GB2096137B (hu)
GR (1) GR76076B (hu)
HK (1) HK4788A (hu)
IE (1) IE52788B1 (hu)
IT (1) IT1148137B (hu)
KE (1) KE3711A (hu)
LU (1) LU84011A1 (hu)
MX (1) MX9203176A (hu)
NL (2) NL190757C (hu)
SE (1) SE447256B (hu)
SG (1) SG30287G (hu)
YU (1) YU43256B (hu)
ZA (1) ZA821359B (hu)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0769297A1 (en) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Use of nefazodone for the manufacture of a medicament for the treatment of panic attack
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
AU2452397A (en) * 1996-07-31 1998-02-20 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6465469B1 (en) 1999-04-09 2002-10-15 Sepracor Inc. S-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6384037B1 (en) 1999-04-09 2002-05-07 Sepracor Inc. R-hydroxynefazodone
CA2356450C (en) 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
AU2003232805A1 (en) * 2002-05-24 2003-12-12 Carl-Fr. Coester Pharmaceutical active substance combination and the use thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
CN1780818A (zh) * 2003-04-30 2006-05-31 Fmc有限公司 苯基取代的环状衍生物
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
AR049382A1 (es) * 2004-05-18 2006-07-26 Fmc Corp Derivados de la urea ciclica substituida
CA2614289A1 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
WO2008086483A2 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US8222254B2 (en) * 2007-08-07 2012-07-17 Prosarix Limited 1, 2, 4-triazole derivatives as serotonergic modulators
US9339500B2 (en) 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
IE52788B1 (en) 1988-03-02
ZA821359B (en) 1983-01-26
ES8305756A1 (es) 1983-04-16
SE8201631L (sv) 1982-09-17
NL8201021A (nl) 1982-10-18
KE3711A (en) 1987-04-30
GR76076B (hu) 1984-08-03
YU43256B (en) 1989-06-30
FR2501690B1 (fr) 1985-07-05
CH649539A5 (de) 1985-05-31
AU555888B2 (en) 1986-10-16
DE3209557C2 (hu) 1993-07-15
GB2096137A (en) 1982-10-13
CA1198436A (en) 1985-12-24
NL970014I1 (nl) 1997-06-02
NL970014I2 (nl) 1997-09-01
DE3209557A1 (de) 1982-12-09
IT1148137B (it) 1986-11-26
FI820856L (fi) 1982-09-17
ES510449A0 (es) 1983-04-16
IE820589L (en) 1982-09-16
ATA104582A (de) 1987-02-15
FI73670C (fi) 1987-11-09
YU52582A (en) 1985-06-30
FR2501690A1 (fr) 1982-09-17
US4338317A (en) 1982-07-06
GB2096137B (en) 1985-01-03
LU84011A1 (fr) 1983-02-22
HK4788A (en) 1988-01-29
NL190757B (nl) 1994-03-01
KR880001374B1 (ko) 1988-07-29
DK158728B (da) 1990-07-09
BE892503A (fr) 1982-09-15
CY1373A (en) 1987-08-07
SG30287G (en) 1987-07-17
FI73670B (fi) 1987-07-31
AU8117082A (en) 1982-09-23
AT384022B (de) 1987-09-25
DK112582A (da) 1982-09-17
JPH0237353B2 (hu) 1990-08-23
IT8247978A0 (it) 1982-03-12
KR830009089A (ko) 1983-12-17
JPS57159774A (en) 1982-10-01
NL190757C (nl) 1994-08-01
SE447256B (sv) 1986-11-03
MX9203176A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
DK158728C (da) Analogifremgangsmaade til fremstilling af triazolon-derivater
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK162991C (da) Analogifremgangsmaade til fremstilling af thiazolidinylalkylenpiperazinderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK453882A (da) Fremgangsmaade til fremstilling af triazinderivater
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK150070C (da) Analogifremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK156722C (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater
DK157873C (da) Analogifremgangsmaade til fremstilling af azinorifamycin-forbindelser
DK156219C (da) Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater
DK156399C (da) Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1997 00025, 970708

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1997 00025, 970708, EXPIRES: 20070312

PUP Patent expired